Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Disease Areas » Cancer » Taproot Health, Five Cancer Centers Agree to Conduct Precision Oncology Master Trial, Share Data

Taproot Health, Five Cancer Centers Agree to Conduct Precision Oncology Master Trial, Share Data

Jan 02, 2020
|
staff reporter

NEW YORK – Taproot Health has signed memorandums of understanding with several National Cancer Institute-designated cancer centers and community oncology clinics to conduct a master observational trial with the aim of collecting and sharing data that will help advance precision oncology. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
09
Featured Webinar

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

Sponsored by
Akoya Biosciences

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context. 

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

What's Popular?

In Cancer

  1. Biodesix Prices $72M IPO

  2. UPDATE: Biocartis, Exact Sciences Terminate Oncotype DX Agreement

  3. Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care

    Premium

  4. Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

  5. Strata Oncology Receives Medicare Coverage for NGS Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.